Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis

For more than five decades, the field of Alzheimer’s disease (AD) has focused on two main hypotheses positing amyloid-beta (Aβ) and Tau phosphorylation (pTau) as key pathogenic mediators. In line with these canonical hypotheses, several groups around the world have shown that the synaptotoxicity in...

Full description

Saved in:
Bibliographic Details
Main Authors: Siddhartha Mondragón-Rodríguez, Humberto Salgado-Burgos, Fernando Peña-Ortega
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2020/2960343
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568596806500352
author Siddhartha Mondragón-Rodríguez
Humberto Salgado-Burgos
Fernando Peña-Ortega
author_facet Siddhartha Mondragón-Rodríguez
Humberto Salgado-Burgos
Fernando Peña-Ortega
author_sort Siddhartha Mondragón-Rodríguez
collection DOAJ
description For more than five decades, the field of Alzheimer’s disease (AD) has focused on two main hypotheses positing amyloid-beta (Aβ) and Tau phosphorylation (pTau) as key pathogenic mediators. In line with these canonical hypotheses, several groups around the world have shown that the synaptotoxicity in AD depends mainly on the increase in pTau levels. Confronting this leading hypothesis, a few years ago, we reported that the increase in phosphorylation levels of dendritic Tau, at its microtubule domain (MD), acts as a neuroprotective mechanism that prevents N-methyl-D-aspartate receptor (NMDAr) overexcitation, which allowed us to propose that Tau protein phosphorylated near MD sites is involved in neuroprotection, rather than in neurodegeneration. Further supporting this alternative role of pTau, we have recently shown that early increases in pTau close to MD sites prevent hippocampal circuit overexcitation in a transgenic AD mouse model. Here, we will synthesize this new evidence that confronts the leading Tau-based AD hypothesis and discuss the role of pTau modulating neural circuits and network connectivity. Additionally, we will briefly address the role of brain circuit alterations as a potential biomarker for detecting the prodromal AD stage.
format Article
id doaj-art-c13d3de12b2f4d0eba99a421552b9ca3
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-c13d3de12b2f4d0eba99a421552b9ca32025-02-03T00:58:44ZengWileyNeural Plasticity2090-59041687-54432020-01-01202010.1155/2020/29603432960343Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau HypothesisSiddhartha Mondragón-Rodríguez0Humberto Salgado-Burgos1Fernando Peña-Ortega2CONACYT National Council for Science and Technology, México, MexicoUADY Neurosciences Department, Autonomous University of Yucatán, 97000 Mérida, Yucatán, MexicoUNAM Developmental Neurobiology and Neurophysiology, Institute of Neurobiology, National Autonomous University of México, Querétaro, MexicoFor more than five decades, the field of Alzheimer’s disease (AD) has focused on two main hypotheses positing amyloid-beta (Aβ) and Tau phosphorylation (pTau) as key pathogenic mediators. In line with these canonical hypotheses, several groups around the world have shown that the synaptotoxicity in AD depends mainly on the increase in pTau levels. Confronting this leading hypothesis, a few years ago, we reported that the increase in phosphorylation levels of dendritic Tau, at its microtubule domain (MD), acts as a neuroprotective mechanism that prevents N-methyl-D-aspartate receptor (NMDAr) overexcitation, which allowed us to propose that Tau protein phosphorylated near MD sites is involved in neuroprotection, rather than in neurodegeneration. Further supporting this alternative role of pTau, we have recently shown that early increases in pTau close to MD sites prevent hippocampal circuit overexcitation in a transgenic AD mouse model. Here, we will synthesize this new evidence that confronts the leading Tau-based AD hypothesis and discuss the role of pTau modulating neural circuits and network connectivity. Additionally, we will briefly address the role of brain circuit alterations as a potential biomarker for detecting the prodromal AD stage.http://dx.doi.org/10.1155/2020/2960343
spellingShingle Siddhartha Mondragón-Rodríguez
Humberto Salgado-Burgos
Fernando Peña-Ortega
Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
Neural Plasticity
title Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
title_full Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
title_fullStr Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
title_full_unstemmed Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
title_short Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis
title_sort circuitry and synaptic dysfunction in alzheimer s disease a new tau hypothesis
url http://dx.doi.org/10.1155/2020/2960343
work_keys_str_mv AT siddharthamondragonrodriguez circuitryandsynapticdysfunctioninalzheimersdiseaseanewtauhypothesis
AT humbertosalgadoburgos circuitryandsynapticdysfunctioninalzheimersdiseaseanewtauhypothesis
AT fernandopenaortega circuitryandsynapticdysfunctioninalzheimersdiseaseanewtauhypothesis